Low quality of reporting adverse drug reactions in paediatric randomised controlled trials

Archives of Disease in Childhood

Volumn 95, Issue 12, 2010, Pages 1023-1026

  De Vries, Tjalling W ^a   Van Roon, Eric N ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; CHILD SAFETY; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; BIOMEDICAL RESEARCH; CHILD; CHILD, PRESCHOOL; DRUG THERAPY; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; PEDIATRICS; PERIODICALS AS TOPIC; PHARMACEUTICAL PREPARATIONS; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78649832568     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.175562     Document Type: Article

References (7)

1. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94.
2. Ioannidis JP, Evans SJ, Gøtzsche PC, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;141:781-8.
3. Ioannidis JP, Contopoulos-Ioannidis DG. Reporting of safety data from randomised trials. Lancet 1998;352:1752-3.
4. Ioannidis JP, Lau J. Improving safety reporting from randomised trials. Drug Saf 2002;25:77-84.
5. Kobbe R, Kreuzberg C, Adjei S, et al. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis 2007;45:16-25.
6. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-9.
7. Anonymous. Promoting safety of medicines for children. Geneva: World Health Organization, 2007.